Experimental HIV Vaccine Clinical Trial Halted In South Africa After Disappointing Results

The Hill: Promising HIV vaccine trial in South Africa fails
“Researchers have halted a trial of a potential HIV vaccine because initial results found the treatment was not effective. The study enrolled just over 5,400 volunteers across South Africa beginning in 2016, but U.S. health officials on Monday said it has failed…” (Weixel, 2/3).

Additional coverage of the trial is available from New York Times and Reuters.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.